Asia Pacific Antibiotics Market Forecast to 2027 - Covid-19 Impact and Regional Analysis by Drug Class (Sulfonamides, Aminoglycosides, Carbapenem, Macrolides, Fluoroquinolones, Penicillin, Cephalosporin, Others); Action Mechanism (Mycolic Acid Inhibitors, RNA Synthesis Inhibitors, DNA Synthesis Inhibitors, Protein Synthesis Inhibitors, Cell Wall Synthesis Inhibitors); and Country
Market Introduction
Antibiotic is a group of medicines that fights bacterial infections, and sometimes protozoan diseases. Moreover, they are used to treat many diseases such as strep throat, urinary tract infections, sinus infections, pneumonia, eye & ear infections, and others. Antibiotics are also called antimicrobials or antibacterial. After the discovery of the antibiotic penicillin in 1920, various other antibiotic compounds have been used to treat several bacterial infections.
Get more information on this report : 
Market Overview and Dynamics
The Asia Pacific antibiotics market is expected to reach US$ 15,784.01 million by 2027 from US$ 11,591.97 million in 2019. The market is estimated to grow with a CAGR of 4.2% from 2020 to 2027. Factors driving the market growth areprevalence of infectious diseases and consolidated government initiatives in emerging economies. However, the tedious and expensive process associated with antibiotic development and impact of COVID-19 pandemic is likely to have a negative impact on market growth.
Key Market Segments
By drug class, the cephalosporins segment accounted for the largest market share in the Asia Pacificantibiotics market in 2019. In terms of action mechanism, the cell wall synthesis inhibitors segment is expected to hold the largest share of the antibiotics market by 2027..
Major Sources and Companies Listed
Some of the major primary and secondary sources for Antibioticsmarket included in the report are, World Health Organization (WHO), Central Drugs Standard Control Organisation (CDSCO), Center for Disease Dynamics, Economics & Policy (CDDEP), and others.
Reasons to buy the report
- To understand the antibiotics market landscape and identifymarket segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for Antibiotics market
- Efficiently plan M&A and partnership dealsin antibiotics market by identifying market segments with the most promising probable sales
- Helps to takeknowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Antibiotics market
- Obtain market revenue forecast for market by various segments from 2019 to 2027 in Asia Pacific region.
ASIA PACIFICANTIBIOTICSMARKET SEGMENTATION
By Drug Class
- Cephalosporin
- Penicillin
- Fluoroquinolones
- Macrolides
- Carbapenem
- Aminoglycosides
- Sulfonamides
- Others
By Action Mechanism
- Cell Wall Synthesis Inhibitors
- Protein Synthesis Inhibitors
- DNA Synthesis Inhibitors
- RNA Synthesis Inhibitors
- Mycolic Acid Inhibitors
- Others
By Geography
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
Company Profiles
- GlaxoSmithKline plc
- Sanofi
- Novartis AG
- Astellas Pharma Inc
- Pfizer Inc
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Antibiotics Market – By Drug Class
1.3.2 Asia Pacific Antibiotics Market – By Action Mechanism
1.3.3 Asia Pacific Antibiotics Market – By Country
2. Asia Pacific Antibiotics Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Antibiotics Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Antibiotics Market - Asia Pacific PEST Analysis
4.3 Expert Opinion
5. Asia Pacific Antibiotics Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Rising Prevalence of Bacterial Infections
5.1.2 Consolidated Government Approach in Emerging Economies
5.2 Key Market Restraints
5.2.1 Tedious and Expensive Process of Antibiotic Development
5.3 Market Opportunities
5.3.1 Growing Investments to Combat Antimicrobial Resistance
5.4 Future Trends
5.4.1 Incorporation of Novel Computing Technologies for Antibiotics Discovery
5.5 Impact analysis
6. Antibiotics Market – Asia Pacific Analysis
6.1 Asia Pacific Antibiotics Market Revenue Forecasts and Analysis
7. Asia Pacific Antibiotics Market Analysis And Forecasts To 2027 – By Drug Class
7.1 Overview
7.2 Asia Pacific Antibiotics market, By Drug Class 2019 & 2027 (%)
7.2.1 Asia Pacific Antibiotics Market Revenue and Forecasts to 2027, By Drug Class (US$ Mn)
7.3 Sulfonamides
7.3.1 Overview
7.3.2 Asia Pacific Sulfonamides Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Aminoglycosides
7.4.1 Overview
7.4.2 Asia Pacific Aminoglycosides Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Carbapenem
7.5.1 Overview
7.5.2 Asia Pacific Carbapenem Market Revenue and Forecasts to 2027 (US$ Mn)
7.6 Macrolides
7.6.1 Overview
7.6.2 Asia Pacific Macrolides Market Revenue and Forecasts to 2027 (US$ Mn)
7.7 Fluoroquinolones
7.7.1 Overview
7.7.2 Asia Pacific Fluoroquinolones Market Revenue and Forecasts to 2027 (US$ Mn)
7.8 Penicillin
7.8.1 Overview
7.8.2 Asia Pacific Penicillin Market Revenue and Forecasts to 2027 (US$ Mn)
7.9 Cephalosporins
7.9.1 Overview
7.9.2 Asia Pacific Cephalosporins Market Revenue and Forecasts to 2027 (US$ Mn)
7.10 Others
7.10.1 Overview
7.10.2 Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)
8. Asia Pacific Antibiotics Market Analysis – By Action Mechanism
8.1 Overview
8.2 Asia Pacific Antibiotics Market, By Action Mechanism 2019-2027 (%)
8.2.1 Asia Pacific Antibiotics Market Revenue and Forecasts to 2027, By Action Mechanism (US$ Mn)
8.3 Mycolic Acid Inhibitors
8.3.1 Overview
8.3.2 Asia Pacific Mycolic Acid Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 RNA Synthesis Inhibitors
8.4.1 Overview
8.4.2 Asia Pacific RNA Synthesis Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 DNA Synthesis Inhibitors
8.5.1 Overview
8.5.2 Asia Pacific DNA Synthesis Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Protein Synthesis Inhibitors
8.6.1 Overview
8.6.2 Asia Pacific Protein Synthesis Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
8.7 Cell Wall Synthesis Inhibitors
8.7.1 Overview
8.7.2 Asia Pacific Cell Wall Synthesis Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
8.8 Others
8.8.1 Overview
8.8.2 Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)
9. Antibiotics Market Revenue and Forecasts To 2027 – Geographical Analysis
9.1 Asia Pacific Antibiotics Market Revenue and Forecasts To 2027
9.1.1 Overview
9.1.2 Asia Pacific: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
9.1.3 Asia Pacific: Antibiotics Market, by Drug Class, 2018–2027 (USD Million)
9.1.4 Asia Pacific: Antibiotics Market, by Action Mechanism, 2018–2027 (USD Million)
9.1.5 Asia Pacific: Antibiotics Market, by Country, 2018 & 2027 (%)
9.1.6 China: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.1.6.1 China: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.1.6.2 China: Antibiotics Market, by Drug Class, 2018–2027 (USD Million)
9.1.6.3 China: Antibiotics Market, by Action Mechanism, 2018–2027 (USD Million)
9.1.7 Japan: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.1 Japan: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.2 Japan: Antibiotics Market, by Drug Class, 2018–2027 (USD Million)
9.1.7.3 Japan: Antibiotics Market, by Action Mechanism, 2018–2027 (USD Million)
9.1.8 India: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.1.8.1 India: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.1.8.2 India: Antibiotics Market, by Drug Class, 2018–2027 (USD Million)
9.1.8.3 India: Antibiotics Market, by Action Mechanism, 2018–2027 (USD Million)
9.1.9 South Korea: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.1.9.1 South Korea: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.1.9.2 South Korea: Antibiotics Market, by Drug Class, 2018–2027 (USD Million)
9.1.9.3 South Korea: Antibiotics Market, by Action Mechanism, 2018–2027 (USD Million)
9.1.10 Australia: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.1.10.1 Australia: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.1.10.2 Australia: Antibiotics Market, by Drug Class, 2018–2027 (USD Million)
9.1.10.3 Australia: Antibiotics Market, by Action Mechanism, 2018–2027 (USD Million)
10. Impact Of COVID-19 Pandemic on Asia Pacific Antibiotics Market
10.1 Asia Pacific: Impact Assessment of COVID-19 Pandemic
11. Company Profiles
11.1 GlaxoSmithKline plc.
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Sanofi
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Novartis AG
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Astellas Pharma Inc.
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Pfizer Inc.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
12. Appendix
12.1 About the Insight Partners
12.2 Glossary of Terms
LIST OF TABLES
Table 1. Asia Pacific Antibiotics Market Revenue and Forecasts To 2027, By Drug Class (US$ Mn)
Table 2. Asia Pacific Antibiotics Market Revenue and Forecasts To 2027, By Action Mechanism (US$ Mn)
Table 3. Asia Pacific Antibiotics Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 4. Asia Pacific Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2027 (USD Million)
Table 5. China Antibiotics Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 6. China Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2027 (USD Million)
Table 7. Japan Antibiotics Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 8. Japan Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2027 (USD Million)
Table 9. India Antibiotics Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 10. India Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2027 (USD Million)
Table 11. South Korea Antibiotics Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 12. South Korea Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2027 (USD Million)
Table 13. Australia Antibiotics Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 14. Australia Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2027 (USD Million)
Table 15. Glossary of Terms, Antibiotics Market
LIST OF FIGURES
Figure 1. Antibiotics Market Segmentation
Figure 2. Asia Pacific Antibiotics Market Overview
Figure 3. Cephalosporin Segment Held Largest Share of Product in Antibiotics Market
Figure 4. India is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Asia Pacific Antibiotics Market - Leading Country Markets (US$ Mn)
Figure 6. Antibiotics Market - Asia Pacific PEST Analysis
Figure 7. Antibiotics market impact analysis of driver and restraints
Figure 8. Asia Pacific Antibiotics market – Revenue Forecasts and Analysis – 2019- 2027
Figure 9. Asia Pacific Antibiotics market, By Drug Class 2019 & 2027 (%)
Figure 10. Asia Pacific Sulfonamides Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 11. Asia Pacific Aminoglycosides Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 12. Asia Pacific Carbapenem Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 13. Asia Pacific Macrolides Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 14. Asia Pacific Fluoroquinolones Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 15. Asia Pacific Penicillin Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 16. Asia Pacific Cephalosporins Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 17. Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 18. Asia Pacific Antibiotics Market, by Action Mechanism 2019 & 2027 (%)
Figure 19. Asia Pacific Mycolic Acid Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. Asia Pacific RNA Synthesis Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. Asia Pacific DNA Synthesis Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 22. Asia Pacific Protein Synthesis Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 23. Asia Pacific Cell Wall Synthesis Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 24. Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 25. Asia Pacific: Antibiotics Market, by Key Country – Revenue (2019) (USD Million)
Figure 26. Asia Pacific Antibiotics Market Revenue and Forecast to 2027 (USD Million)
Figure 27. China: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
Figure 28. Japan: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
Figure 29. India: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
Figure 30. South Korea: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
Figure 31. Australia: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
Figure 32. Impact of Covid-19 Pandemic in Asia-Pacific Country Markets
The List of Companies - Asia Pacific Antibiotics Market
- GlaxoSmithKline plc
- Sanofi
- Novartis AG
- Astellas Pharma Inc
- Pfizer Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia PacificAntibiotics Market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global breast cancer screening market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth regional market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.